Literature DB >> 15727225

Lessons from the neuropathology of atypical forms of multiple sclerosis.

C Stadelmann1, W Brück.   

Abstract

Multiple sclerosis (MS) is characterized by multiple demyelinated inflammatory lesions disseminated in the central nervous system (CNS). Additional features of MS pathology include axonal loss and gliosis. Remyelination may take place predominantly in the early stages of lesion formation. Pathologically, important inter-individual differences have been observed with respect to oligodendrocyte preservation. Furthermore, different mechanisms of demyelination, such as T-cell/macrophage-mediated demyelination, antibody/complement-mediated demyelination, and primary damage of the oligodendrocyte have been observed in individual MS patients. Atypical MS forms, such as Marburg's acute MS, Devic's neuromyelits optica, Balò's concentric sclerosis, and Schilder's diffuse sclerosis share key aspects of MS pathology, however, each of them harbors characteristic discriminative features. Devic's neuromyelitis optica may represent the prototypical disease with antibody/complement-mediated demyelination, whereas cases with Balò's concentric sclerosis show oligodendrocyte dystrophy. Acute disseminated encephalomyelitis (ADEM) may be regarded as a related condition lacking extensive demyelination. Thus, atypical MS forms may help to elucidate pathogenic mechanisms in MS.

Entities:  

Mesh:

Year:  2004        PMID: 15727225     DOI: 10.1007/s10072-004-0333-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

1.  Marburg's disease: a diagnostic dilemma.

Authors:  Kirti Gupta; Rakesh Kumar Vasishta; Param Singh Kharbanda; Sameer Vyas; Sudesh Prabhakar
Journal:  Neurol Sci       Date:  2011-08-06       Impact factor: 3.307

2.  Clinicopathological considerations in acute disseminated encephalomyelitis (ADEM): a fulminant case with favorable outcome.

Authors:  Lucas Schirmer; Christian L Seifert; Sabine Pfeifenbring; Silke Wunderlich; Christine Stadelmann; Bernhard Hemmer
Journal:  J Neurol       Date:  2011-09-08       Impact factor: 4.849

3.  A mighty mouse: building a better model of multiple sclerosis.

Authors:  Richard M Ransohoff
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

4.  Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.

Authors:  Masahiko Nakamura; Toru Nakazawa; Hiroshi Doi; Takehiro Hariya; Kazuko Omodaka; Tatsuro Misu; Toshiyuki Takahashi; Kazuo Fujihara; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-19       Impact factor: 3.117

5.  Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis.

Authors:  R T Naismith; N T Tutlam; J Xu; E C Klawiter; J Shepherd; K Trinkaus; S-K Song; A H Cross
Journal:  Neurology       Date:  2009-03-24       Impact factor: 9.910

6.  The origins of concentric demyelination: self-organization in the human brain.

Authors:  Roman H Khonsari; Vincent Calvez
Journal:  PLoS One       Date:  2007-01-17       Impact factor: 3.240

7.  Autopsy-proven demyelination associated with infliximab treatment.

Authors:  Michael J Bradshaw; Bret C Mobley; Jeffrey P Zwerner; Subramaniam Sriram
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-01-27

8.  A Case of Marburg's Variant of Multiple Sclerosis Successfully Treated with IVIg and Mitoxantrone.

Authors:  Adarsh Manuel; Madabhushi Chakravarthy Vasudevan
Journal:  Ann Indian Acad Neurol       Date:  2021-02-16       Impact factor: 1.383

Review 9.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.